| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.4 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.01 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-12 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.006 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.007 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.05 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |